Teleflex Incorporated (NYSE:TFX) Receives $144.00 Average Target Price from Brokerages

Teleflex Incorporated (NYSE:TFX) has been assigned a consensus recommendation of “Hold” from the ten ratings firms that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation and four have given a buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $146.00.

A number of research analysts recently issued reports on TFX shares. Mizuho set a $140.00 price objective on Teleflex in a research note on Friday, May 8th. Truist Financial restated a “hold” rating and set a $143.00 target price (up from $135.00) on shares of Teleflex in a research note on Monday, May 11th. Wall Street Zen downgraded shares of Teleflex from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Needham & Company LLC increased their price objective on shares of Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Finally, Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price objective on the stock in a research report on Monday, April 13th.

Institutional Investors Weigh In On Teleflex

A number of hedge funds have recently bought and sold shares of TFX. AQR Capital Management LLC grew its stake in shares of Teleflex by 478.1% in the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after buying an additional 1,956,811 shares in the last quarter. Abrams Bison Investments LLC bought a new position in shares of Teleflex in the 3rd quarter valued at about $112,317,000. Irenic Capital Management LP bought a new stake in Teleflex during the first quarter worth approximately $104,061,000. Norges Bank bought a new stake in shares of Teleflex in the 4th quarter valued at approximately $66,076,000. Finally, Wolf Hill Capital Management LP purchased a new stake in Teleflex during the 4th quarter valued at $47,405,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Down 0.2%

Shares of TFX stock opened at $135.45 on Wednesday. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. Teleflex has a 12 month low of $100.18 and a 12 month high of $139.67. The stock has a market cap of $6.00 billion, a P/E ratio of -5.93, a P/E/G ratio of 0.98 and a beta of 0.82. The company has a 50 day simple moving average of $127.90 and a two-hundred day simple moving average of $118.52.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The business had revenue of $548.30 million for the quarter, compared to analysts’ expectations of $536.91 million. During the same quarter last year, the company posted $1.44 EPS. The company’s revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, research analysts expect that Teleflex will post 6.73 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, May 25th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Friday, May 22nd. Teleflex’s dividend payout ratio (DPR) is presently -5.96%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.